vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Global Business Travel Group, Inc. (GBTG). Click either name above to swap in a different company.

Global Business Travel Group, Inc. is the larger business by last-quarter revenue ($792.0M vs $487.7M, roughly 1.6× CLOVER HEALTH INVESTMENTS, CORP.). Global Business Travel Group, Inc. runs the higher net margin — 10.5% vs -10.1%, a 20.6% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 34.0%). Global Business Travel Group, Inc. produced more free cash flow last quarter ($13.0M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 13.9%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

A travel management company (TMC) is a travel agency which manages organizations' corporate or business travel programs. Such companies will often provide an end-user online booking tool, mobile application, program management, and consulting teams, executive travel services, meetings and events support, reporting functionality, duty of care, and more. Non-Profit travel management companies also provide services to manage complex visa requirements, pre-trip medical needs, remote area travel, ...

CLOV vs GBTG — Head-to-Head

Bigger by revenue
GBTG
GBTG
1.6× larger
GBTG
$792.0M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+10.7% gap
CLOV
44.7%
34.0%
GBTG
Higher net margin
GBTG
GBTG
20.6% more per $
GBTG
10.5%
-10.1%
CLOV
More free cash flow
GBTG
GBTG
$82.0M more FCF
GBTG
$13.0M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
13.9%
GBTG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
GBTG
GBTG
Revenue
$487.7M
$792.0M
Net Profit
$-49.3M
$83.0M
Gross Margin
Operating Margin
-10.1%
3.7%
Net Margin
-10.1%
10.5%
Revenue YoY
44.7%
34.0%
Net Profit YoY
-123.2%
692.9%
EPS (diluted)
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
GBTG
GBTG
Q4 25
$487.7M
$792.0M
Q3 25
$496.6M
$674.0M
Q2 25
$477.6M
$631.0M
Q1 25
$462.3M
$621.0M
Q4 24
$337.0M
$591.0M
Q3 24
$331.0M
$597.0M
Q2 24
$356.3M
$625.0M
Q1 24
$346.9M
$610.0M
Net Profit
CLOV
CLOV
GBTG
GBTG
Q4 25
$-49.3M
$83.0M
Q3 25
$-24.4M
$-62.0M
Q2 25
$-10.6M
$15.0M
Q1 25
$-1.3M
$75.0M
Q4 24
$-22.1M
$-14.0M
Q3 24
$-9.2M
$-128.0M
Q2 24
$7.4M
$27.0M
Q1 24
$-19.2M
$-19.0M
Gross Margin
CLOV
CLOV
GBTG
GBTG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
GBTG
GBTG
Q4 25
-10.1%
3.7%
Q3 25
-4.9%
1.8%
Q2 25
-2.2%
5.4%
Q1 25
-0.3%
8.9%
Q4 24
-6.4%
5.1%
Q3 24
-2.7%
4.5%
Q2 24
2.0%
6.7%
Q1 24
-6.5%
2.6%
Net Margin
CLOV
CLOV
GBTG
GBTG
Q4 25
-10.1%
10.5%
Q3 25
-4.9%
-9.2%
Q2 25
-2.2%
2.4%
Q1 25
-0.3%
12.1%
Q4 24
-6.6%
-2.4%
Q3 24
-2.8%
-21.4%
Q2 24
2.1%
4.3%
Q1 24
-5.5%
-3.1%
EPS (diluted)
CLOV
CLOV
GBTG
GBTG
Q4 25
$0.16
Q3 25
$-0.13
Q2 25
$0.03
Q1 25
$0.16
Q4 24
$-0.04
Q3 24
$-0.28
Q2 24
$0.06
Q1 24
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
GBTG
GBTG
Cash + ST InvestmentsLiquidity on hand
$78.3M
$434.0M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$308.7M
$1.6B
Total Assets
$541.0M
$4.9B
Debt / EquityLower = less leverage
0.88×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
GBTG
GBTG
Q4 25
$78.3M
$434.0M
Q3 25
$427.0M
Q2 25
$601.0M
Q1 25
$552.0M
Q4 24
$194.5M
$536.0M
Q3 24
$288.0M
$524.0M
Q2 24
$254.8M
$515.0M
Q1 24
$208.3M
$475.0M
Total Debt
CLOV
CLOV
GBTG
GBTG
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.4B
Q1 25
$1.4B
Q4 24
$1.4B
Q3 24
$1.4B
Q2 24
Q1 24
Stockholders' Equity
CLOV
CLOV
GBTG
GBTG
Q4 25
$308.7M
$1.6B
Q3 25
$340.9M
$1.5B
Q2 25
$344.2M
$1.2B
Q1 25
$336.1M
$1.1B
Q4 24
$341.1M
$1.1B
Q3 24
$342.2M
$1.1B
Q2 24
$324.9M
$1.2B
Q1 24
$292.5M
$1.2B
Total Assets
CLOV
CLOV
GBTG
GBTG
Q4 25
$541.0M
$4.9B
Q3 25
$559.7M
$4.8B
Q2 25
$575.0M
$3.9B
Q1 25
$583.7M
$3.8B
Q4 24
$580.7M
$3.6B
Q3 24
$653.0M
$3.8B
Q2 24
$674.2M
$3.8B
Q1 24
$671.8M
$3.8B
Debt / Equity
CLOV
CLOV
GBTG
GBTG
Q4 25
0.88×
Q3 25
0.91×
Q2 25
1.15×
Q1 25
1.23×
Q4 24
1.32×
Q3 24
1.26×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
GBTG
GBTG
Operating Cash FlowLast quarter
$-66.9M
$52.0M
Free Cash FlowOCF − Capex
$-69.0M
$13.0M
FCF MarginFCF / Revenue
-14.1%
1.6%
Capex IntensityCapex / Revenue
0.4%
4.9%
Cash ConversionOCF / Net Profit
0.63×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
GBTG
GBTG
Q4 25
$-66.9M
$52.0M
Q3 25
$12.1M
$71.0M
Q2 25
$5.4M
$57.0M
Q1 25
$-16.3M
$53.0M
Q4 24
$34.8M
$65.0M
Q3 24
$50.0M
$85.0M
Q2 24
$44.8M
$73.0M
Q1 24
$25.9M
$49.0M
Free Cash Flow
CLOV
CLOV
GBTG
GBTG
Q4 25
$-69.0M
$13.0M
Q3 25
$11.4M
$38.0M
Q2 25
$4.8M
$27.0M
Q1 25
$-16.5M
$26.0M
Q4 24
$33.3M
$33.0M
Q3 24
$49.6M
$59.0M
Q2 24
$44.4M
$49.0M
Q1 24
$25.5M
$24.0M
FCF Margin
CLOV
CLOV
GBTG
GBTG
Q4 25
-14.1%
1.6%
Q3 25
2.3%
5.6%
Q2 25
1.0%
4.3%
Q1 25
-3.6%
4.2%
Q4 24
9.9%
5.6%
Q3 24
15.0%
9.9%
Q2 24
12.5%
7.8%
Q1 24
7.3%
3.9%
Capex Intensity
CLOV
CLOV
GBTG
GBTG
Q4 25
0.4%
4.9%
Q3 25
0.1%
4.9%
Q2 25
0.1%
4.8%
Q1 25
0.0%
4.3%
Q4 24
0.5%
5.4%
Q3 24
0.1%
4.4%
Q2 24
0.1%
3.8%
Q1 24
0.1%
4.1%
Cash Conversion
CLOV
CLOV
GBTG
GBTG
Q4 25
0.63×
Q3 25
Q2 25
3.80×
Q1 25
0.71×
Q4 24
Q3 24
Q2 24
6.04×
2.70×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

GBTG
GBTG

Travel$620.0M78%
Other$172.0M22%

Related Comparisons